S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Luxoft Holding, Inc. Announces Approval of the Reorganization of IBS Group Holding Limited|
|Installed Building Products Announces Acquisition of Midwest Insulation Installer|
|Synergy Pharmaceuticals Presents Positive Phase 2b Study Results for Plecanatide in Patients with Irritable Bowel Syndrome with Constipation|
|Synergy Pharmaceuticals to Present Additional Positive Phase 2b Study Results for Plecanatide in Patients with Irritable Bowel Syndrome with Constipation at ACG 2014 Annual Scientific Meeting|
|Ironwood Pharmaceuticals Initiates Phase III Trial of 72 mcg Linaclotide in Adult Patients with Chronic Idiopathic Constipation|
|Mellanox Delivers the World’s Fastest EDR 100Gb/s InfiniBand Switch With Latency Less Than 90 Nanoseconds|
|Neurocrine Biosciences Reports Third Quarter 2014 Results|
|Supermicro® Exhibits the Industry's Broadest Range of HPC Optimized Platforms and New Ultra SuperServer® Solutions at Supercomputing '14|
|Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients|
|Synthetic Biologics Appoints Prominent Gastrointestinal (GI) Key Opinion Leaders to Irritable Bowel Syndrome (IBS) Clinical Advisory Board|
Click above to view more mutual fund data and stats for ibs - Ibersol SGPS SA.